Aterian director David Natan files initial beneficial ownership statement
ATER•Form 3 filing
- Aterian director David Natan filed an initial Form 3 on July 29, 2026.
Related News
Lōkahi Therapeutics Advances Lt-100 Development Strategy Toward Single-Injection Administration
GCTK•
Graphic Packaging declares quarterly dividend of $0.11 a share
GPK•
Charles Schwab Chief Risk Officer Nigel J. Murtagh disposes of 32,947 common shares for $3.43 million
SCHW•
Starbucks raises annual forecasts again as turnaround takes root
SBUX•
Immunitybio Receives UAE Marketing Authorization For Anktiva In Bladder and Lung Cancer
IBRX•